MyFinsight
Home
Blog
About
Contact
Download
Download image
Represents the amount of
proceeds from issuance of...
-$5,907,319
Represents the amount of
proceeds from issuance of...
$4,102,740
Net cash provided by
financing activities
$6,825,151
Canceled cashflow
$3,184,908
Cash, cash
equivalent, restricted...
-$2,339,594
Canceled cashflow
$6,825,151
Stock-based compensation
expense
$599,306
Paid-in-kind interest
$379,254
Prepaid expenses
-$169,351
Represents the amount of
gain loss on...
-$127,083
Increase (decrease) in
accounts payable and...
$44,650
Increase (decrease) in
accounts payable,...
$30,747
Represents the amount of
operating lease...
$26,402
Repayment of new debenture
$3,184,908
Net cash used in
operating activities
-$8,969,688
Canceled cashflow
$1,376,793
Effect of exchange rate
on cash, cash...
-$195,057
Net loss for the year
-$9,042,311
Increase (decrease) in
accounts payable, trade
-$1,263,656
Increase (decrease) in
operating lease liability
-$40,514
Back
Back
Cash Flow
source: myfinsight.com
Medicus Pharma Ltd. (MDCXW)
Medicus Pharma Ltd. (MDCXW)